Rosi v. Aclaris Therapeutics, Inc.

Full title: LINDA ROSI, Plaintiff, v. ACLARIS THERAPEUTICS, INC. et al, Defendants.

Court: United States District Court, S.D. New York

Date published: Nov 29, 2021

19-cv-7118 (LJL) (S.D.N.Y. Nov. 29, 2021)

Opinion

19-cv-7118 (LJL)

11-29-2021

LINDA ROSI, Plaintiff, v. ACLARIS THERAPEUTICS, INC. et al, Defendants.

LEWIS J. LIMAN, UNITED STATES DISTRICT JUDGE:

ORDER

LEWIS J. LIMAN, UNITED STATES DISTRICT JUDGE:

As the parties are aware, the settlement hearing int his case is scheduled for tomorrow, Tuesday, November 30, 2021.

It is hereby ORDERED that, by 6:00 p.m. today, plaintiff is directed to provide the Court with:

• Citations for all cases in the past ten years in which the fee award in a securities class action represented 2:5 or less of the lodestar multiplier;

• Citations for cases in which the award to the lead plaintiff is less than $10,000 per lead plaintiff;

• Support for the hours that the lead plaintiff purportedly spent on the case; and

• Detailed contemporaneous time records to support the lodestar analysis.

SO ORDERED.